GoingToMeet

This meeting will focus on the opportunities presented by the growing contribution of emerging genomic information and technologies to interdisciplinary approaches in the study of variable responses of humans to drugs and toxic agents, and how research may benefit the individual. The meeting will provide an in depth focus on diverse areas including the biochemistry and physiology of drug action, uptake and metabolism, and how this is affected by genetics; the opportunities for discovery and design of new therapeutic agents; personalizing medicine; understanding and managing adverse drug reactions; the impact of academic and commercial initiatives; ethical, legal, regulatory and social consequences of genetics applied to medicines.

The meeting will include two sessions devoted to major global pharmacogenomics research initiatives. These sessions are intended to highlight recent advances in global pharmacogenomics research and to stimulate collaborations through sample sharing and data/knowledge sharing.

We aim to bring together senior and junior investigators, postdoctoral and postgraduate researchers, medical, regulatory and ethical experts in a range of disciplines to share existing research and experience, and to explore the potential of working together in new international and interdisciplinary research areas for the benefit of individual patients.